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OBJECTIVES The objective was to assess the prevalence of subclavian artery stenosis (SS) in four cohorts
(two free-living and two clinical populations) and determine both risk factors for this
condition and the association with other cardiovascular conditions.
BACKGROUND The prevalence of SS in the general population is unknown, and its association with risk
factors and other cardiovascular diseases is not well-established.
METHODS A total of 4,223 subjects (2,975 from two free-living cohorts and 1,248 from two clinical
cohorts) were included in this cross-sectional analysis. Subclavian artery stenosis was defined
as 15 mm Hg interarm pressure difference.
RESULTS The prevalence of SS was 1.9% in the free-living cohorts and 7.1% in the clinical cohorts; SS
was significantly (p  0.05) associated with past smoking (odds ratio [OR]  1.80), current
smoking (OR  2.61), and higher levels of systolic blood pressure (OR  1.90 per 20 mm
Hg). Higher levels of high-density lipoprotein (HDL) cholesterol were inversely and
significantly associated with SS (OR  0.87 per 10 mg/dl). In regression analyses relating SS
to other cardiovascular diseases, the only significant finding was with peripheral arterial
disease (PAD) (OR  5.11, p  0.001).
CONCLUSIONS Significant SS is present in approximately 2% of the free-living population and 7% of the
clinical population. Additionally, SS is correlated with current and past smoking histories,
systolic blood pressure, HDL levels (inversely), and the presence of PAD. These findings
suggest that bilateral brachial blood pressure measurements should routinely be performed in
patients with an elevated risk profile, both to screen for SS, and to avoid missing a
hypertension or PAD diagnosis because of unilateral pressure measurement in an obstructed
arm. (J Am Coll Cardiol 2004;44:618–23) © 2004 by the American College of Cardiology
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opper extremity blood pressure differences are usually due
o atherosclerotic plaque, resulting in a reduction in blood
ressure to one upper extremity, or less commonly, both
pper extremities (1). Nonatherosclerotic conditions that
an also result in interarm systolic pressure differences, such
s Takayasu’s arteritis or radiation-induced vascular disease,
re quite rare in North America (2–6). Currently, a bilateral
rachial artery blood pressure measurement is the standard
or screening for significant obstruction (stenosis/occlusion)
f the proximal vasculature supplying the upper extremity.
pper extremity atherosclerotic obstruction is predomi-
antly due to subclavian artery stenosis (SS), although on
he right side, where the subclavian artery branches off the
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Manuscript received February 18, 2004; revised manuscript received April 4, 2004,bccepted April 16, 2004.nnominate artery (as opposed to directly from the aortic
rch on the left side), up to a third of the obstructions are
ctually in the innominate artery (7,8). For convenience, we
ere refer to a interarm systolic blood pressure (SBP)
ifference of at least 15 mm Hg as SS, realizing that perhaps
s many as 15% of such cases are actually in the innominate
rtery.
S in select populations. Clinicians have continued to
ebate what brachial SBP difference is “clinically signifi-
ant.” Previous research has shown the interarm difference
n individuals without known cardiovascular pathology does
ot favor one arm and does not vary by gender or age
4,9–12). Furthermore, in a population of subjects (n 
00) with significant cardiovascular risk factors, Lane et al.
13) employed univariate analyses to demonstrate that
ncreased age was the only significant predictor of SBP
ifferences of both 10 mm Hg and 20 mm Hg, while
ender, ethnicity, arm circumference, handedness, hyper-
ension, diabetes, and cardiovascular disease were not sig-
ificantly predictive. Lower extremity peripheral arterial
isease (PAD) was not assessed. They reported a prevalence
n this selected population of 10% having an interarm
ressure difference of 15 mm Hg. In a small angiographic
tudy (n  52), Gutierrez et al. (14) reported that 41.6%
f patients with PAD had stenosis of at least one of the
rachiocephalic arteries, and 18.7% had more than a 50%
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August 4, 2004:618–23 Epidemiology of Subclavian Artery Stenosisiameter stenosis of the left subclavian artery. Additionally,
nvestigators have reported angiographic prevalences of left
S between 0.5% and 4% in populations of patients with
oronary artery disease (CAD) (15). Frank et al. (16)
xamined the association with various interarm pressure
ifferences and clinical risk factors/CAD/PAD on a small
cale (n  134). Though that study failed to identify a
elationship to gender, age, smoking, hypertension, diabe-
es, or CAD, but did demonstrate a significant relationship
etween having PAD and a systolic interarm pressure
ifference of 10 mm Hg, 15 mm Hg, 20 mm Hg, or
45 mm Hg.
Despite the suggested correlation between SS and PAD
nd the implications of SS for clinical diagnostic measure-
ents, there has not been a large-scale study of the
revalence of or risk factors for SS in a free-living popula-
ion. Furthermore, the relationship between SS and other
therosclerotic diseases, such as PAD, CAD, and stroke has
eceived little attention. In this study we quantified the
revalence of SS in subjects in two free-living populations
cohorts A and B) and patients in two clinical groups
cohorts C and D), analyzed risk factors for SS, and
xplored the association between SS and the prevalence
f three other atherosclerotic diseases: PAD, stroke, and
AD.
ETHODS
ata. A total of 4,223 subjects (composite cohort) were
ncluded in the cross-sectional analysis. They represented four
istinct cohorts: two (cohorts A and B) were from community
opulation studies (17–19) and two (cohorts C and D) were
rom clinical studies enriched with vascular patients (20,21).
fter informed consent, subject information concerning de-
ographic data, risk factors, and previous and current cardio-
ascular disease was determined variously by standardized
ubject interview, medical record review, primary care physi-
ian questionnaire, and physical examination.
In all studies, patient ethnicity was self-reported and was
lassified as non-Hispanic white (NHW), African Ameri-
an, Hispanic, or Other. “Systolic hypertension” was de-
ned as SBP140 mm Hg or previous physician diagnosis.
Pack-years” was defined as the average number of cigarettes
Abbreviations and Acronyms
ABI  ankle brachial index
CABG coronary artery bypass graft
CAD  coronary artery disease
HDL  high-density lipoprotein
MI  myocardial infarction
NHW  non-Hispanic white
PAD  peripheral arterial disease
PTCA  percutaneous transluminal coronary angioplasty
SBP  systolic blood pressure
SS  subclavian artery stenosismoked per day during the years smoked divided by 20 and eultiplied by the number of years the subjects had smoked.
tandardized laboratory tests were used to measure choles-
erol levels. The concentration of high-density lipoprotein
HDL) cholesterol was determined using a direct enzymatic
olorimetric assay in all cohorts (22).
“Coronary artery disease” was defined as having had a
yocardial infarction (MI), percutaneous transluminal cor-
nary angioplasty (PTCA), or coronary artery bypass graft
CABG) surgery (standardized electrocardiogram informa-
ion or a history of angina was not available for all subjects).
he definition of “stroke” was a previous physician diagnosis
f the condition. Patients were defined as having “PAD”
f they had an ankle brachial index (ABI)0.90 in either leg
r if they had already undergone surgery/angioplasty for
AD in either leg. This ABI threshold has been shown to
e 90% sensitive and 98% specific for angiographically
iagnosed PAD (23). For the purposes of this research, “SS”
as defined as an interarm pressure difference of 15 mm
g. Participants provided written consent for participation
n the studies and the use of their data for future research.
nstitutional review board approval was obtained at the time
f data collection from the University of California, San
iego (Cohorts A, B, and D) and Northwestern University
nd Catholic Health Partners Hospital (Cohort C). Fur-
hermore, institutional review board approval was obtained
or the current research project.
ohorts definitions. Cohort A consisted of 624 individu-
ls who were all members of a geographically defined
opulation study as part of a Lipid Research Clinics
rotocol (1978 to 1979) (17,19). The subjects were initially
ecruited through an introductory letter and telephone call
nd were all residents of a predominantly white, upper
iddle class community in southern California. A total
f 59 subjects (9.4%) were excluded because of missing data.
he remaining population used in the analysis consisted
f 45.3% (n  256) men and 54.7% (n  309) women with
mean age of 65.9  10.4 (range, 38 to 82) years. This
opulation was all NHW.
Cohort B consisted of 2,410 individuals who were re-
ruited between 1995 to 1999 (18). They were randomly
elected within categories of gender, age, and ethnicity from
database of current and retired employees of the University
f California, San Diego. This allowed an oversampling
f minorities and women to increase power for testing
elected hypotheses. The spouse or significant other of each
andomly selected participant was also invited to participate
n the study. The population consisted of 34.2% (n  825)
en and 65.8% (n 1,585) women with a mean age of 59.3
11.4 (range, 29 to 91) years. This population was 59.7%
HW, 13.5% African American, 14.6% Hispanic, and
2.2% other ethnicities.
Cohort C was composed of 740 individuals from a
atient population in the Chicago area recruited between
998 and 2000 (20). This cohort consisted of vascular
aboratory and general medicine patients. Patients were
xcluded if they were wheelchair bound, had foot/leg
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Epidemiology of Subclavian Artery Stenosis August 4, 2004:618–23mputations, were nursing home residents, non-English
peaking, or had dementia. Additionally, patients with an
BI 1.50 were excluded because of possible arterial
tiffness and thereby inaccurate pressure measurement (20).
he population consisted of 56.2% (n  416) men and
3.8% (n  324) women with a mean age of 70.9  8.4
range, 55 to 93) years. This population was 78.1% NHW,
7.2% African American, 1.5% Hispanic, and 3.1% other
thnicities. A total of 62.4% of this cohort had PAD.
Cohort D included 508 patients who had visited the San
iego Veterans Administration Medical Center or the
niversity of California, San Diego Medical Center vascu-
ar laboratories between 1990 and 1994 (21). The popula-
ion consisted of 88.2% (n  448) men and 11.8% (n  60)
omen with a mean age of 68.6  9.1 (range, 40 to 100)
ears. This population was 86.8% NHW, 4.5% African
merican, 5.5% Hispanic, and 2.8% other ethnicities. A
otal of 65.9% of the patients in this cohort had PAD.
lood pressure and ABI measurement. Blood pressure
easurement protocols differed slightly among the four co-
orts. However, each of the methods used have been shown to
roduce accurate (and therefore comparable) results. To sum-
arize, subjects in cohorts A and D had sequential measure-
ents of brachial and ankle pressures, using 12 cm pneumatic
uffs (Hokanson, Bellevue, Washington, model SC-12) and
ither a mercury-in-silastic gauge (cohort A) or a photople-
hysmographic sensor attached to the great toe (cohort D).
he pressure at the site of the cuff was the pressure measured.
he ABI in each leg for these cohorts was calculated using the
easured ankle systolic pressure divided by the highest brachial
lood pressure (left vs. right). Subjects in cohort B had SBPs
easured sequentially in each arm, in addition to two mea-
Table 1. Demographic Information for the Co
Po
Age (SD)
Male
Ethnicity
NHW
AA
Hispanic
Other
Age- and gender-adjusted categorical variables
Diabetes
Systolic hypertension (140 mm Hg)
Past smoker
Current smoker
PAD
Stroke
CAD
Age- and sex-adjusted continuous variables
Mean pack-yrs‡
Mean total cholesterol (mg/dl)
Mean HDL (mg/dl)
*Population cohorts include cohorts A and B; clinical cohort
smoked.
AA  African American; CAD  coronary artery disease
PAD  peripheral arterial disease (ankle-brachial index 0urements in each posterior tibial artery, using a CW Doppler 1ith a 5 Mhz transducer (Medasonics, Mountain View,
alifornia). The ABI was calculated by dividing the average
osterior tibial artery pressure from each side by the brachial
rtery measurement in the arm with the highest pressure. The
ressures of subjects in cohort C were measured sequentially
sing a hand-held Doppler probe (Nicolet Vascular Pocket
op II, Golden, Colorado). Each site had two sequential
easurements taken. The ABI for each leg was calculated by
ividing the highest average leg artery systolic pressure (either
nterior tibial or posterior tibial) by the highest average brachial
ressure (right vs. left).
tatistical methods. All analyses were cross-sectional. The
opulation cohorts (A and B) and the clinical cohorts (C
nd D) were examined separately for prevalence estimates.
ultiple logistic regression analyses were conducted as a
eans of assessing independent effects on brachial blood
ressure differences. The variables for gender, race, smoking
tatus, diabetes, PAD, stroke, and MI/CABG/PTCA were
ncluded as categorical variables. Systolic blood pressure,
ge, HDL, and total cholesterol were included as continu-
us variables. Because systolic pressures were recorded
ounded to the nearest 5 mm Hg in cohort A, pressures in
ohorts B, C, and D were similarly rounded for uniformity
f analyses. All analyses were performed using SPSS version
0.0 for Macintosh (SPSS Inc., Chicago, Illinois).
ESULTS
s shown in Table 1, the population cohorts (A and B) were
omposed of 2,975 subjects, with a mean (SD) age of 60.5
11.5) years, of whom 36.3% (n  1,081) were male. The
ample was 67.4% NHW, 10.9% African American, and
ion Cohorts*
2,975
Clinical Cohorts*
n  1,248
Total Cohort
n  4,223
.5 (11.5) 70.0 (8.8) 63.3 (11.6)
36.3% 69.2% 46.1%
67.4% 81.7% 71.6%
10.9% 12.0% 11.2%
11.9% 3.1% 9.3%
9.8% 3.0% 7.8%
4.3% 16.9% 8.0%
37.0% 46.5% 39.8%
46.1% 52.0% 47.8%
7.2% 23.2% 12.0%
7.3% 60.2% 22.9%
1.8% 12.2% 4.9%
6.4% 29.9% 13.4%
11.5 35.6 18.6
14.9 192.6 208.7
54.7 43.9 51.7
de cohorts C and D; ‡Includes only patients who have ever
 high-density lipoprotein; NHW  non-Hispanic white;
revious PAD surgery).horts
pulat
n 
60
2
s inclu
; HDL1.9% Hispanic. The clinical cohorts (C and D) were
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8.8). A total of 69.2% (n  864) of the subjects were male,
nd 30.8% were female. This sample was 81.7% NHW,
2.0% African American, and 3.1% Hispanic. As expected,
he clinical cohorts had a higher prevalence of cardiovascular
isk factors than the population cohorts including more
iabetes, more systolic hypertension, and more extensive
moking histories (Table 1). Furthermore, the clinical co-
orts had a greater proportion of patients with a history of
AD, a previous stroke, or CAD.
Interarm SBP differences, right minus left, in each of the
our cohorts are shown in Table 2. The mean interarm
ressure difference in the two population cohorts was
ymmetrically distributed around zero, with the 10th per-
entile having the identical absolute value as the 90th, and
he 5th percentile the same as the 95th, in both populations.
n contrast, the two clinical cohorts were skewed signifi-
antly toward higher pressures in the right arm (t test, p 
.001), with the 90th and 95th percentiles exceeding the
0th and 5th percentile absolute values, respectively, in both
ohorts.
Based on previous research by English et al. (15) implying
high specificity at a 15 mm Hg interarm pressure differ-
nce threshold, we selected this cut-point for defining SS.
f those in the combined cohort with an interarm differ-
able 2. Brachial Blood Pressure Differences in the Population a
nterarm Differences (Right Arm Minus Left Arm)
Mean (SD) Median
opulation cohorts
Cohort A (n  565) 0.107 (6.9) 0
Cohort B (n  2,410) 0.105 (5.5) 0
linical cohorts
Cohort C (n  740) 2.25 (9.6) 2
Cohort D (n  508) 1.17 (8.2) 0
ombined cohorts 0.494 (7.0) 0
Table 3. The Prevalence of Subclavian Stenosi
Prevalence (95% CI)
Population Coh
1.9% (1.
Age 50 yrs 1.4% (0.
Age 50–59 yrs 1.5% (0.
Age 60–69 yrs 1.7% (0.
Age 70 yrs 2.7% (1.
NHW 2.3% (1.
AA 0.6% (0.
Hispanic 1.7% (0.
Other 0.4% (0.
Current or past smoker 2.2% (1.
Ever diabetic 1.6% (0.
Ever hypertensive 2.5% (1.
PAD 10.1% (6.
Ever had a stroke 2.5% (0.
CAD 1.5% (0.
*Subclavian stenosis was defined as an interarm systolic bloo
to determine the prevalence in ages 50 years; ‡cohort C e
AA  African American; CAD  coronary artery diseas
 peripheral arterial disease (ankle brachial index 0.9 or previounce of at least 15 mm Hg, 66.7% (n  94) had a greater
ressure in the right than in the left arm. Furthermore,
sborn et al. (24) demonstrated in a population of CABG
andidates that a 15 mm Hg difference identified all
atients (n  59) with at least a 50% subclavian artery
arrowing, and none of the patients with a 10 to 14 mm Hg
ifference has significant subclavian artery narrowing.
As shown in Table 3, the calculated prevalence (95%
onfidence interval) of SS in the population cohorts was
.9% (1.8% in males and 1.9% in females). The prevalence
f SS increased with age, from 1.4% in subjects below 50
ears to 2.7% in subjects over the age of 70 years. As
xpected, there was a much greater prevalence of SS in the
linical cohorts: 6.0% in males and 9.7% in females. The
revalence of SS in the clinical cohorts increased from 4.3%
n subjects aged 50 to 59 to 8.7% in subjects over 70 years
f age.
ultivariable models. In order to evaluate the appropriate-
ess of combining the four cohorts for multivariate analysis,
ogistic regression models were run with each of the four
ohorts for cardiovascular diseases and risk factors separately
eight models total), as well as for the population cohorts
ombined and the clinical cohorts combined for cardiovascular
iseases and risk factors separately (four additional models).
he results in these 12 models were quite consistent, the major
linical Cohorts Showing the Percentile Distributions of
Percentile
5 10 50 75 90 95
10 10 0 0 10 10
8 6 0 2 6 8
10.5 8 2 6.5 12 16.5
5 0 0 0 4 10
8 6 0 2 7 10
opulation Cohorts and Clinical Cohorts*
 2,885) Clinical Cohort (n  1,227)†
) 7.1% (5.7, 8.7)
) N/A
) 4.3% (1.6, 9.0)‡
) 5.8% (3.8, 8.4)
) 8.7% (6.6, 11.1)
) 6.0% (4.6, 7.6)
) 14.0% (8.8, 20.8)
) 10.5% (2.9, 24.8)
) 8.3% (1.8, 22.5)
) 7.4% (5.9, 9.2)
) 8.0% (4.6, 12.6)
) 8.5% (6.7, 10.7)
6) 9.3% (7.3, 11.5)
2) 8.7% (4.8, 14.2)
) 6.0% (3.9, 8.7)
sure of 15 mm Hg; †there was an insufficient sample size
d individuals less than age 55.
 confidence interval; NHW  non-Hispanic white; PADnd C




s in P
ort (n
4, 2.4
6, 2.6
8, 2.7
9, 2.9
7, 4.1
7, 3.1
1, 2.2
6, 3.8
0, 1.9
5, 3.0
2, 5.6
6, 3.8
0, 15.
1, 13.
2, 5.3
d pres
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e; CIs PAD surgery)
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Epidemiology of Subclavian Artery Stenosis August 4, 2004:618–23ifference being a somewhat higher risk estimate for PAD in
he population than clinical cohorts. Nonetheless, in all four
ohorts, the PAD association with SS was positive, indepen-
ent, and highly significant.
We examined the independent effect of risk factors and
ther cardiovascular diseases on the presence of SS using
ultivariate logistic regression models. We did not analyze
model predicting SS by both cardiovascular risk factors
nd diseases simultaneously, because risk factors associated
ith both SS and other cardiovascular diseases would show
spuriously weakened association with SS in such a model
25). The first model addressed risk factors (Table 4). The
econd model (Table 5) addressed cardiovascular diseases
PAD, stroke, and CAD).
Table 4 shows a significant (p value  0.05) association
f age, SBP, the subject’s smoking history, and HDL levels
ith SS. For each decade of age, the risk of SS increased
.21 times, and for a 20 mm Hg increase in SBP, the risk
ncreased 1.90 times. Compared with subjects who had
ever smoked, those who had only smoked in the past had
able 4. Clinical Characteristics Associated With the Presence
ersus Absence of Subclavian Stenosis: Results of Multiple
ogistic Regression Analysis (n  3,895)*
Variable† Odds Ratio p Value
ge (per 10 yrs) 1.21 0.041
emale† 1.16 0.439
A‡ 0.70 0.231
ispanic‡ 1.14 0.688
ther‡ 0.73 0.462
iabetes 1.10 0.731
ast smoker§ 1.80 0.005
urrent smoker§ 2.61 0.001
rachial SBP (per 20 mm Hg) 1.90 0.001
DL (per 10 mg/dl) 0.87 0.018
otal cholesterol (per 20 mg/dl) 0.98 0.694
Subclavian stenosis was defined as an interarm systolic blood pressure (SBP) of 15
m Hg; model summary: 2 Log likelihood  1196.774; Nagelkerke R Square 
.130; †male gender is the reference category; ‡non-Hispanic white is the reference
ategory; §having never smoked is the reference category; measured in the arm with
he highest pressure.
AA  African American; HDL  high-density lipoprotein.
able 5. Cardiovascular Diseases Associated With the Presence
ersus Absence of Subclavian Stenosis: Results of Multiple
ogistic Regression Analysis (n  4,102)*
Variable† Odds Ratio p Value
ge (per 10 yrs) 1.31 0.001
emale† 1.18 0.311
A‡ 1.51 0.064
ispanic‡ 1.35 0.330
ther‡ 0.80 0.584
AD 5.11 0.001
troke 1.02 0.938
AD 0.66 0.050
Subclavian stenosis was defined as an interarm systolic blood pressure of 15 mm
g; model summary: 2 Log likelihood  1366.641; Nagelkerke R square  0.110;
male gender is the reference category. ‡non-Hispanic white is the reference category.
AA  African American; CAD  coronary artery disease (previous myocardial
nfarction or undergone a percutaneous transluminal coronary angioplasty/coronary
rtery bypass graft); PAD  peripheral arterial disease (ankle-brachial index 0.9 orprevious PAD surgery).1.80 times greater risk of SS, and current smokers a 2.61
imes greater risk. Though total cholesterol was not signif-
cantly predictive, increased HDL showed a protective
ffect: every 10 mg/dl increase in HDL reduced the risk
f having SS by 13.1%. In the cardiovascular disease model
Table 5), PAD was shown to be strongly predictive of SS;
ncreasing the risk by 5.11 times. Age was significantly
ssociated with SS, but gender, ethnicity, previous stroke,
nd CAD were not. The borderline inverse association
etween CAD and SS (odds ratio  0.66, p  0.050) may
ave been an artifact of the strong association between
AD and PAD, because the univariate association between
AD and SS was positive.
ISCUSSION
sing angiographic information as a gold standard, English
t al. (15) have suggested that an interarm pressure differ-
nce of 15 mm Hg has a sensitivity of approximately 50%
nd a specificity of 90% for detecting SS. The relatively low
ensitivity/high specificity is likely due either to stenoses
hat are not significant enough to cause significant blood
ressure differences, or to bilateral stenoses. This suggests
hat the actual prevalence of significant subclavian obstruc-
ion is greater than the prevalence based on 15 mm Hg
nterarm pressure difference.
As expected, the prevalence of SS in the clinical popula-
ion (7.1%) was strikingly higher than the prevalence in the
ree-living population (1.9%). English et al. (15) reported a
revalence of left SS of 1.5% in patients with no PAD, 4.3%
n hypertensive patients, 4.3% in patients with a history
f smoking, 6.8% in patients with diabetes mellitus, 7.6% in
atients with cerebrovascular disease, and 11.5% in patients
ith PAD. A reason for the somewhat lower prevalence
f SS in the clinical cohorts in our study was the proportion
f individuals without PAD (approximately one-third) in
hese cohorts. Furthermore, in addition to establishing the
ndependent associations of age, current and past smoking
istory, SBP, and HDL on the interarm pressure difference,
he multivariate logistic analyses highlighted the close rela-
ionship between SS and PAD.
The chief limitation of this study was that blood pressure
easurement is an indirect method of detecting SS. How-
ver, in the study by English, et al. (15), the sensitivity of a
5 mm Hg interarm blood pressure threshold for subclavian
tenosis was approximately 50%, and the specificity was
pproximately 90%. This threshold was also supported in a
mall scale study by Osborne, et al. (24). In conditions with
ow prevalence, such as subclavian stenosis, at a given level
f sensitivity and specificity, the positive predictive value
ill be lower, and the negative predictive value higher than
t higher prevalence levels. One clinical implication of the
oderate sensitivity of the interarm pressure difference test
s that our data likely underestimate the true prevalence
f subclavian stenosis. Another limitation is that the clinical
opulations included all patients referred to the vascular
l
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revalence of subclavian stenosis is somewhat lower than the
xpected prevalence, based on previous studies of PAD
atients.
linical implications. The Seventh Report of the Joint
ational Committee on Prevention, Detection, Evaluation,
nd Treatment of High Blood Pressure (JNC VII) empha-
izes the importance of bilateral brachial blood pressure
easurement (26). One justification for this requirement is
hat stenosis of the subclavian artery is typically asymptom-
tic, and, thus, unilateral measurement can result in an
naccurate estimation of systemic blood pressure. Unilateral
easurement can be hazardous to the patient, potentially
eading to a lack of treatment and/or optimal control
f hypertension. Because blood pressure is often higher
hen the patient first enters the office, it is important for the
atient to sit relaxed for a few minutes so that the most
ccurate bilateral blood pressures can be obtained (26). If an
nterarm systolic pressure difference of 10 mm Hg or greater
s found, we believe this finding should be rechecked later in
he visit for verification.
The finding that PAD was the strongest single predictor
f SS emphasizes the importance of using the highest
rachial pressure for the ABI denominator. A unilateral or
verage brachial pressure measurement could result in a
alsely normal ABI (27) and a missed diagnosis of PAD
28). These findings emphasize the importance of bilateral
lood pressure measurements, particularly in patients with
ecognized risk factors or PAD, to facilitate proper recog-
ition and management of cardiovascular pathology.
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